Beyond Meat Posts Downbeat Q4 Results, Joins RH, ORIC Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Beyond Meat Inc (NASDAQ: BYND) reported fourth-quarter revenue of $61.59 million, falling short of analyst expectations of $62.57 million, and posted an adjusted loss of 29 cents per share, missing estimates for a loss of 13 cents. As a result, shares plummeted 10.9% to $0.62 in pre-market trading. The company joins other stocks like ORIC Pharmaceuticals and RH, which also experienced significant declines in pre-market trading.